Healthcare / Medical Care FacilitiesKuala Lumpur
$0.11
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-3.9M · quality 38.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
35/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$110M
P/E
N/A
•EV/EBITDA
8.6x
↓ROE
0.5%
↑Gross Margin
56.1%
↑Debt/Equity
0.99
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+18.7%
FCF CAGR
-50.2%
FCF margin
0.7%
FCF / Net income
2.97x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $87.0M · net income $205738.0 · FCF $611780.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $87.0M | $87.0M | $55.8M | $67.7M | $52.0M |
| Net Income | $205738.00 | $205738.00 | $-19.6M | $2.5M | $9.6M |
| EBITDA | $16.9M | $16.9M | $-7.2M | $13.9M | $18.1M |
| EPS | — | — | -0.02 | 0.00 | 0.01 |
| Gross Margin | 56.1% | 56.1% | 38.1% | 56.7% | 56.2% |
| Operating Margin | 4.1% | 4.1% | -33.9% | 9.6% | 26.0% |
| Net Margin | 0.2% | 0.2% | -35.2% | 3.7% | 18.4% |
| Balance Sheet | |||||
| Debt/Equity | 0.99 | 0.99 | 0.87 | 0.36 | 1.59 |
| Current Ratio | 1.01 | 1.01 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $611780.00 | $611780.00 | $-3.9M | $-12.4M | $5.0M |
| Returns | |||||
| ROE | 0.5% | 0.5% | -43.9% | 3.9% | 63.5% |
| Valuation | |||||
| P/E | — | — | — | 144.64 | — |
| EV/EBITDA | 8.62 | 8.62 | — | 27.18 | — |
| P/B | 2.44 | 2.44 | 4.01 | 5.59 | — |
| Growth & Yield | |||||
| Revenue Growth | 55.9% | 55.9% | -17.6% | 30.3% | — |
| EPS Growth | — | — | -803.6% | -70.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-26.7%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.02 → n/d
Residual
-26.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.